Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Walker

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
Hypertension (Dallas, Tex. : 1979)|April 22, 2009
Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressureRebecca M Reynolds, Brian R Walker, David I Phillips, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruationMick Rae, Amirah Mohamad, Deborah Price, et al.
Neuropharmacology|December 16, 2014
Short-term inhibition of 11β-hydroxysteroid dehydrogenase type 1 reversibly improves spatial memory but persistently impairs contextual fear memory in aged miceNicola Wheelan, Scott P Webster, Christopher J Kenyon, et al.
Diabetologia|August 8, 2015
Convergence in insulin resistance between very severely obese and lean women at the end of pregnancyShareen Forbes, Sarah M Barr, Rebecca M Reynolds, et al.
Frontiers in Endocrinology|October 30, 2014
β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell DestructionXiaoxia Liu, Sophie Turban, Roderick N Carter, et al.
Neuropharmacology|February 6, 2014
Inhibiting 11β-hydroxysteroid dehydrogenase type 1 prevents stress effects on hippocampal synaptic plasticity and impairs contextual fear conditioningR Angela Sarabdjitsingh, Ming Zhou, Joyce L W Yau, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitorsScott P Webster, Peter Ward, Margaret Binnie, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and CaucasiansRobert S Lindsay, Deborah J Wake, Saraswathy Nair, et al.
Endocrinology|November 26, 2009
Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levelsElise L V Malavasi, Val Kelly, Nikita Nath, et al.
Talanta|October 5, 2014
Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometryRita Upreti, Gregorio Naredo, Abdullah M M Faqehi, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Hypertension (Dallas, Tex. : 1979)|April 22, 2009
Programming of hypertension: associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressureRebecca M Reynolds, Brian R Walker, David I Phillips, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2009
Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruationMick Rae, Amirah Mohamad, Deborah Price, et al.
Neuropharmacology|December 16, 2014
Short-term inhibition of 11β-hydroxysteroid dehydrogenase type 1 reversibly improves spatial memory but persistently impairs contextual fear memory in aged miceNicola Wheelan, Scott P Webster, Christopher J Kenyon, et al.
Diabetologia|August 8, 2015
Convergence in insulin resistance between very severely obese and lean women at the end of pregnancyShareen Forbes, Sarah M Barr, Rebecca M Reynolds, et al.
Frontiers in Endocrinology|October 30, 2014
β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell DestructionXiaoxia Liu, Sophie Turban, Roderick N Carter, et al.
Neuropharmacology|February 6, 2014
Inhibiting 11β-hydroxysteroid dehydrogenase type 1 prevents stress effects on hippocampal synaptic plasticity and impairs contextual fear conditioningR Angela Sarabdjitsingh, Ming Zhou, Joyce L W Yau, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitorsScott P Webster, Peter Ward, Margaret Binnie, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and CaucasiansRobert S Lindsay, Deborah J Wake, Saraswathy Nair, et al.
Endocrinology|November 26, 2009
Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levelsElise L V Malavasi, Val Kelly, Nikita Nath, et al.
Talanta|October 5, 2014
Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometryRita Upreti, Gregorio Naredo, Abdullah M M Faqehi, et al.
Pageof 22